Tumour-homing peptides: tools for targeting, imaging and destruction
Authors:
- 20 July 2007
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 35 (4) , 780-783
Abstract
Each normal organ and pathological condition contains organ- or disease-specific molecular tags on its vasculature that constitute a vascular ‘zip code’ system. Tissue-selective tumour metastasis may also depend on vascular addresses. We have used phage display peptide libraries to map disease-specific differences in the vasculature. By using this technology, we have isolated several peptides which are targeted specifically to tumour blood vessels, lymphatic vessels and/or tumour cells. Some of the tumour-homing peptides recognize common angiogenesis markers and are capable of binding to several types of tumour, whereas other peptides recognize tumour-type-specific differences. We have also shown that the vasculature of a pre-malignant lesion differs from that of a full-blown tumour and also from the vasculature of the corresponding normal organ. Our peptides have revealed molecules that act as novel biomarkers of this vascular heterogeneity. Interestingly, some of our homing peptides are able to penetrate the target cells. This internalization differs from that of the Tat, penetratins and other related peptides in that our peptides enter the cell in a cell-type-specific manner. These peptides appear to be able to concentrate in the target tissue, making them particularly efficient delivery vectors for the targeting of drugs, other therapeutic moieties and imaging agents.Keywords
This publication has 24 references indexed in Scilit:
- Lymphatic Zip Codes in Premalignant Lesions and TumorsCancer Research, 2006
- Molecular Profiling of Heart Endothelial CellsCirculation, 2005
- Inhibition of Tumor Growth by Intramuscular Injection of cDNA Encoding Tumor Necrosis Factor α Coupled to NGR and RGD Tumor-Homing PeptidesHuman Gene Therapy, 2004
- Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselsJournal of Cell Biology, 2003
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.Journal of Clinical Investigation, 1998
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Organ targeting In vivo using phage display peptide librariesNature, 1996
- De Novo Antimicrobial Peptides with Low Mammalian Cell ToxicityJournal of Medicinal Chemistry, 1996
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993